Skip to search formSkip to main contentSkip to account menu

CVD Regimen

Known as: Cisplatin-Vinblastine-DTIC Regimen, Cisplatin-Vinblastine-Dacarbazine Regimen 
A regimen consisting of cisplatin, vinblastine and dacarbazine used for the treatment of advanced-stage or metastatic malignant melanoma.
National Institutes of Health

Related topics

Related topics

6 relations
CisplatinDacarbazineVinblastinecisplatin/dacarbazine/vinblastine protocol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1997
Review
1997
Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy.
Biochemotherapy, which uses recombinant interferon alpha (rIFN-alpha) and recombinant interleukin-2 (rIL-2) in combination with… 
1994
1994
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results.
During the conduct of a biochemotherapy trial in which cisplatin, vinblastine and dacarbazine (CVD) were administered… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)